1
|
Small W Jr, Bacon MA, Bajaj A, Chuang LT,
Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR,
Viswanathan AN and Gaffney DK: Cervical cancer: A global health
crisis. Cancer. 123:2404–2412. 2017. View Article : Google Scholar : PubMed/NCBI
|
2
|
Song S, Song C, Kim HJ, Wu HG, Kim JH,
Park NH, Song YS, Kim JW, Kang SB and Ha SW: 20 year experience of
postoperative radiotherapy in IB-IIA cervical cancer patients with
intermediate risk factors: Impact of treatment period and
concurrent chemotherapy. Gynecol Oncol. 124:63–67. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
National Comprehensive Cancer Network, .
NCCN Clinical Practice Guidelines in Oncology (NCCN
Guidelines®): Cervical Cancer. National Comprehensive
Cancer Network, Inc.; 2018
|
4
|
Peters WA III, Liu PY, Barrett RJ II,
Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr and
Alberts DS: Concurrent chemotherapy and pelvic radiation therapy
compared with pelvic radiation therapy alone as adjuvant therapy
after radical surgery in high-risk early-stage cancer of the
cervix. J Clin Oncol. 18:1606–1613. 2000. View Article : Google Scholar : PubMed/NCBI
|
5
|
Rosa DD, Medeiros LR, Edelweiss MI,
Pohlmann PR and Stein AT: Adjuvant platinum-based chemotherapy for
early state cervical cancer. Cochrane Database Syst Rev.
6:CD0053422012.PubMed/NCBI
|
6
|
Landoni F, Maneo A, Colombo A, Placa F,
Milani R, Perego P, Favini G, Ferri L and Mangioni C: Randomised
study of radical surgery versus radiotherapy for stage Ib-IIa
cervical cancer. Lancet. 350:535–540. 1997. View Article : Google Scholar : PubMed/NCBI
|
7
|
Sartori E, Tisi G, Chiudinelli F, La Face
B, Franzini R and Pecorelli S: Early stage cervical cancer:
Adjuvant treatment in negative lymph node cases. Gynecol Oncol. 107
(1 Suppl 1):S170–S174. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ryu SY, Park SI, Nam BH, Cho CK, Kim K,
Kim BJ, Kim MH, Choi SC, Lee ED and Lee KH: Is adjuvant
chemoradiotherapy overtreatment in cervical cancer patients with
intermediate risk factors? Int J Radiat Oncol Biol Phys.
79:794–799. 2011. View Article : Google Scholar : PubMed/NCBI
|
9
|
Sedlis A, Bundy BN, Rotman MZ, Lentz SS,
Muderspach LI and Zaino RJ: A randomized trial of pelvic radiation
therapy versus no further therapy in selected patients with stage
IB carcinoma of the cervix after radical hysterectomy and pelvic
lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol.
73:177–183. 1999. View Article : Google Scholar : PubMed/NCBI
|
10
|
Rogers L, Siu SS, Luesley D, Bryant A and
Dickinson HO: Radiotherapy and chemoradiation after surgery for
early cervical cancer. Cochrane Database Syst Rev.
5:CD0075832012.PubMed/NCBI
|
11
|
World Medical Association, . World medical
association declaration of Helsinki: Ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194. 2013.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Kim HS and Song YS: International
federation of gynecology and obstetrics (FIGO) staging system
revised: What should be considered critically for gynecologic
cancer? J Gynecol Oncol. 20:135–136. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
U.S. Department of Health and Human
Services, . Common Terminology Criteria for Adverse Events Version
5.0 (CTCAE v5.0). https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5×7.pdfNovember
27–2017
|
14
|
Ebina Y, Mikami M, Nagase S, Tabata T,
Kaneuchi M, Tashiro H, Mandai M, Enomoto T, Kobayashi Y, Katabuchi
H, et al: Japan society of gynecologic oncology guidelines 2017 for
the treatment of uterine cervical cancer. Int J Clin Oncol.
24:1–19. 2019. View Article : Google Scholar : PubMed/NCBI
|
15
|
Gien LT, Beauchemin MC and Thomas G:
Adenocarcinoma: A unique cervical cancer. Gynecol Oncol.
116:140–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Jung EJ, Byun JM, Kim YN, Lee KB, Sung MS,
Kim KT and Jeong DH: Cervical adenocarcinoma has a poorer prognosis
and a higher propensity for distant recurrence than squamous cell
carcinoma. Int J Gynecol Cancer. 6:1228–1236. 2017. View Article : Google Scholar : PubMed/NCBI
|
17
|
Wu SY, Huang EY and Lin H: Optimal
treatments for cervical adenocarcinoma. Am J Cancer Res.
9:1224–1234. 2019.PubMed/NCBI
|
18
|
Marin F, Plesca M, Bordea CI, Moga MA and
Blidaru A: Types of radical hysterectomies: From Thoma Ionescu and
Wertheim to present day. J Med Life. 7:172–176. 2014.PubMed/NCBI
|
19
|
Kunieda F, Kasamatsu T, Arimoto T, Onda T,
Toita T, Shibata T, Fukuda H and Kamura T; Gynecologic Cancer Study
Group of the Japan Clinical Oncology Group, : Non-randomized
confirmatory trial of modified radical hysterectomy for patients
with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical
cancer: Japan Clinical Oncology Group Study (JCOG1101). Jpn J Clin
Oncol. 45:123–126. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Konishi I: The Okabayashi radical
hysterectomy: Basic principle and step-by-step procedure. Surg J (N
Y). 7 (Suppl 2):S57–S69. 2021. View Article : Google Scholar : PubMed/NCBI
|
21
|
Turner JE: Basic information for radiation
therapy referral. Q Bull Northwest Univ Med Sch. 35:76–86.
1961.PubMed/NCBI
|
22
|
Hu K, Wang W, Liu X, Meng Q and Zhang F:
Comparison of treatment outcomes between squamous cell carcinoma
and adenocarcinoma of cervix after definitive radiotherapy or
concurrent chemoradiotherapy. Radiat Oncol. 13:2492018. View Article : Google Scholar : PubMed/NCBI
|
23
|
Lee YJ, Kim YT, Kim S, Lee B, Lim MC, Kim
JW and Won YJ: Prognosis of cervical cancer in the era of
concurrent chemoradiation from national database in Korea: A
comparison between squamous cell carcinoma and adenocarcinoma. PLoS
One. 10:e01448872015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Galic V, Herzog TJ, Lewin SN, Neugut AI,
Burke WM, Lu YS, Hershman DL and Wright JD: Prognostic significance
of adenocarcinoma histology in women with cervical cancer. Gynecol
Oncol. 125:287–291. 2012. View Article : Google Scholar : PubMed/NCBI
|
25
|
Shigeta S, Shimada M, Tsuji K, Nagai T,
Tanase Y, Matuo K, Kamiura S, Iwata T, Yokota H and Mikami M: Risk
assessment in the patients with uterine cervical cancer harboring
intermediate risk factors after radical hysterectomy: A
multicenter, retrospective analysis by the Japanese gynecologic
oncology group. Int J Clin Oncol. 27:1507–1515. 2022. View Article : Google Scholar : PubMed/NCBI
|